Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the...
Tenx seems to hold support at prior resistance. This stock can go up further if the structure holds.
This stock is at a key support level, if it gets more volume we can expect a bullish rally.
A new drop post divergence on a significant timeframe signifies a possible start of a new move. In this case down. It 's impossible to tell what it is at this early stage, only that more ground to the South will be covered.
Tenax Therapeutics, Inc., a specialty pharmaceutical company, engages in identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada.
Pupm&Dump trading strategy idea. $TENX is rising without clear preconditions today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $2,00; stop-loss — $2,78; take-profit — $1,22; Do not view this idea as a recommendation for trading or...
Company currently in the process of development of levosimendan for Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF). Efforts included a successful pre-IND meeting with the FDA in April 2018, which allowed the existing Phase II clinical protocol to be used for PH-HFpEF. During the summer and fall, the company...
As the company has been experiencing a worrisome valuation over the last year. (Especially regarding their revenue stream and quanitification of their approach towards the years to come). Be diligent however, there is always some room for support. Not Investment advice. For educational and Analytical obeservation only.
Tuesday holds a big gamble for $TENX. Hopefully the overnight price hike isn't inflated due to the REV STOCK SPLIT just revealed late on 12/29. Either way, Chris Moody's RSI indicator still shows a positive trend line . I'm hoping for a push up to 0.59 on Jan 2, but it's going to be a stressful morning. Huge thanks to @Avasreader for helping me walk through this...
you can see the support line and the resistance. the strategy is: buy now or keep an eye of what you boght, and wait for the resistence then split it and sell some, if it goes down sell everything, but if it goes up' just wait or buy more untill it will reach for the target ! good luck !
Pattern target to be 1.17 NASDAQ:TENX